Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares ...
A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...
Russell's Pharmacy & Shoppe's last day on Angier Avenue is October 19. Its closure comes as independent pharmacies around the ...
TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a ...
1don MSN
The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" ...
CVS Health (CVS) stock receives an upgrade from TD Cowen to Buy with a price target of $85, based on favorable Medicare ...
Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...
CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Rhyee ...
Today’s pharmacy innovations provide employees with expanded choices to meet their health care needs. As a result, they ...
Pharmacists, lawmakers call for transparency in prescription drug costs as small businesses struggle
The bill, which was introduced July 23 in the House, is aimed at implementing a pharmacy reimbursement model to use national ...
Looking for undervalued stocks? Here are the top undervalued stocks in November 2024. Check out the list here.
College students are facing troubles obtaining birth control on some campuses amid contraceptive deserts and changes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback